EZH2 and metabolic disease: Increased expression of EZH2 seems to be associated with metabolic disorders since mTORC1-mediated glycolysis controls EZH2 expression in SLE T cells, suggesting that glycolytic pathways might be indirect targets for suppressing EZH2 expression [226].